Reaching Out. Giving Hope. Improving Lives.
In 2017, Pharmerit established Caremerit to promote and lead the company’s corporate social responsibility efforts. Our aim is to improve our world and our local communities around us by sharing our skills and knowledge to help those in need of care.
It is part of our culture and how we live out our mission: to improve patient access to medical care through evidence, worldwide.
This employee-driven program is made up of representatives from each office location and Center of Excellence – a truly global Pharmerit initiative. Caremerit’s goal is to live out our mission in a hands-on way, by promoting and supporting health internally and in the communities around us.
Pharmerit’s Caremerit team has developed strategic goals in the following areas:
Supporting Communities – We seek to create a healthier world, one community at a time. Volunteer contributions include: support projects, sport fundraising events, and the sponsoring of scientific and educational organizations like ISPOR and AMCP
Environmental Sustainability – We believe we need to support humanity’s most urgent goals, including the need to improve quality of life for people around the globe while reducing our impact on our environment. We have implemented facilities for waste management, incorporated green design standards and concepts into our new offices, and applied technology to solve global challenges.
Empowering Employees – We are committed to creating a diverse and inclusive workplace environment where our employees can deliver their best every day.
“Making direct contributions to the health of the community around me through Caremerit activities makes my work at Pharmerit even more enriching and impactful.”
Modeling and Meta-Analysis
Developing tools to inform policy decision-makers about the clinical and health-economic consequences of health technologies
Including the patient perspective to better understand their needs, design better studies, and assess how they value different therapies
Informing decision-making with evidence from “real-world” practice
Strategic Market Access
Communicating the evidence regarding unmet needs and the benefits and costs of treatment innovation to ensure market access and reimbursement